234 related articles for article (PubMed ID: 18568357)
21. Severe seborrhoeic dermatitis: side-effect of the Mirena intra-uterine system.
Karri K; Mowbray D; Adams S; Rendal JR
Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):53-4. PubMed ID: 16546818
[TBL] [Abstract][Full Text] [Related]
22. Progestin-releasing intrauterine systems and leiomyoma.
Kaunitz AM
Contraception; 2007 Jun; 75(6 Suppl):S130-3. PubMed ID: 17531604
[TBL] [Abstract][Full Text] [Related]
23. Transmural migration and perforation of a levonorgestrel intrauterine system: a case report and review of the literature.
Ferguson CA; Costescu D; Jamieson MA; Jong L
Contraception; 2016 Jan; 93(1):81-6. PubMed ID: 26386445
[TBL] [Abstract][Full Text] [Related]
24. Successful pregnancy following insertion of a levonorgestrel-releasing intrauterine system in two infertile patients with complex atypical endometrial hyperplasia.
Qi X; Zhao W; Duan Y; Li Y
Gynecol Obstet Invest; 2008; 65(4):266-8. PubMed ID: 18196936
[TBL] [Abstract][Full Text] [Related]
25. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S
Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692
[TBL] [Abstract][Full Text] [Related]
26. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders.
Lukes AS; Reardon B; Arepally G
Fertil Steril; 2008 Sep; 90(3):673-7. PubMed ID: 18001734
[TBL] [Abstract][Full Text] [Related]
27. Treatment of menorrhagia with an LNG-IUS.
Pakarinen P; Luukkainen T
Contraception; 2007 Jun; 75(6 Suppl):S118-22. PubMed ID: 17531601
[TBL] [Abstract][Full Text] [Related]
28. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L
Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221
[TBL] [Abstract][Full Text] [Related]
29. Modern management of abnormal uterine bleeding: the levonorgestrel intra-uterine system.
Mansour D
Best Pract Res Clin Obstet Gynaecol; 2007 Dec; 21(6):1007-21. PubMed ID: 17544330
[TBL] [Abstract][Full Text] [Related]
30. New frameless and framed intrauterine devices and systems - an overview.
Wildemeersch D
Contraception; 2007 Jun; 75(6 Suppl):S82-92. PubMed ID: 17531623
[TBL] [Abstract][Full Text] [Related]
31. Term pregnancy with intraperitoneal levonorgestrel intrauterine system: a case report and review of the literature.
Hopkins MR; Agudelo-Suarez P; El-Nashar SA; Creedon DJ; Rose CH; Famuyide AO
Contraception; 2009 Apr; 79(4):323-7. PubMed ID: 19272503
[TBL] [Abstract][Full Text] [Related]
32. Cytological evaluation and investigation of the vaginal flora of long-term users of the levonorgestrel-releasing intrauterine system (LNG-IUS).
Lessard T; Simões JA; Discacciati MG; Hidalgo M; Bahamondes L
Contraception; 2008 Jan; 77(1):30-3. PubMed ID: 18082663
[TBL] [Abstract][Full Text] [Related]
33. Menstrual blood loss in women using the frameless FibroPlant LNG-IUS.
Andrade A; Wildemeersch D
Contraception; 2009 Feb; 79(2):134-8. PubMed ID: 19135571
[TBL] [Abstract][Full Text] [Related]
34. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
35. [Hysteroscopy to relieve IUD-related symptoms].
de Groot PC; Kapiteijn K; Siemans F
Ned Tijdschr Geneeskd; 2010; 154():A2298. PubMed ID: 21176259
[TBL] [Abstract][Full Text] [Related]
36. Intrauterine devices and intrauterine systems.
ESHRE Capri Workshop Group
Hum Reprod Update; 2008; 14(3):197-208. PubMed ID: 18400840
[TBL] [Abstract][Full Text] [Related]
37. [Levonorgestrel-releasing intrauterine device (Mirena) and breast cancer: what do we learn from literature for clinical practice?].
Boutet G
Gynecol Obstet Fertil; 2006 Nov; 34(11):1015-23. PubMed ID: 17092752
[TBL] [Abstract][Full Text] [Related]
38. Management of levonorgestrel-releasing intrauterine system (LNG-IUS) uterine perforation.
Margarit LM; Griffiths AN; Vine SJ
J Obstet Gynaecol; 2004 Aug; 24(5):586-7. PubMed ID: 15369954
[No Abstract] [Full Text] [Related]
39. Mirena at caesarean section.
Puzey M
Eur J Contracept Reprod Health Care; 2005 Sep; 10(3):164-7. PubMed ID: 16318963
[TBL] [Abstract][Full Text] [Related]
40. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
Sheng J; Zhang WY; Zhang JP; Lu D
Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
